Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up

Eur Neurol. 2004;52(1):61-3. doi: 10.1159/000079547. Epub 2004 Jul 5.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Creatine Kinase / blood
  • Dermatomyositis / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Methotrexate / therapeutic use
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / physiopathology
  • Polymyositis / drug therapy*
  • Prednisone / therapeutic use
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Anti-Inflammatory Agents
  • Antibodies
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Creatine Kinase
  • Prednisone
  • Methotrexate